Using Influenza Vaccination Location Data from the 2018 Behavioral Risk Factor Surveillance System (BRFSS) to Expand COVID-19 Vaccination Coverage

Fonzi, Victoria; Thapa, Kiran; Luitel, Kishor; Padilla, Heather M.; Harris, Curt; Khan, M. Mahmud; Nowak, Glen; Rajbhandari‐Thapa, Janani

doi:10.3390/ijerph18157753

Cited by 3 publications

(9 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The Federal Retail Pharmacy Program (FRPP) is a collaboration between the United States (US) federal government and 21 national public-private pharmacy partnerships representing over 40,000 pharmacy locations to increase access and directly supply COVID-19 vaccines across all 50 states [10][11][12]. These vital partnerships between the federal government and pharmacy partners will help increase the distribution of the vaccines.…”

Section: Description Of the Policymentioning

confidence: 99%

“…Private and public partnerships can ensure that the COVID vaccine supply is equally and effectively disseminated to the general population. The FRPP utilizes the social vulnerability index (SVI) tool to make informed, evidence-based decisions about which areas could benefit the most from the vaccine distribution program to ensure equity and evaluate the vaccine distribution plan [ 10 , 11 ].…”

Section: Description Of the Policymentioning

confidence: 99%

“…With roughly over 60,000 pharmacies nationwide, over 60% of pharmacies are represented within the FRPP. Within the FRPP, over 26,246 make up the retail pharmacy stores that belong to a chain, while the other half belong to independent pharmacies [ 10 ]. With good demand, supply, and outreach within metropolitan and non-metropolitan areas, these pharmacies can serve a substantial US population.…”

Section: Benefits Of the Policymentioning

confidence: 99%

“…The FRPP created extensive partnerships that made the US one of the first countries to transition from vaccine scarcity to abundance [ 10 ]. The benefit of these private and public partnerships is that pharmacies are often the first point of contact for the public to get information about vaccinations [ 2 ].…”

Section: Benefits Of the Policymentioning

confidence: 99%

“…The vaccine allocation was in a phased approach. The phased approach led to inconsistent supply flows and poor federal support; thus, pharmacies experienced intermittent vaccine supplies and interruptions to the normal supply chain channels [ 5 , 10 ]. In addition, the vaccines were disproportionately allocated based on geographic areas, as hard-to-reach/remote areas with non-established partners experienced delays in receiving the vaccines from the phased rollout.…”

Section: Limitations Of the Policymentioning

confidence: 99%

See 4 more Smart Citations

The Federal Retail Pharmacy Program (FRPP) Impact on COVID-19 Vaccine Distribution During Pandemic: Effectiveness, Limitations, and Implications

Wilson

Aremu²

2022

Innov Pharm

View full text Add to dashboard Cite

The coronavirus disease 2019 (COVID-19) has altered the healthcare landscape for pharmacy practice and continues its global onslaught. As the COVID-19 vaccines began to reach the general population, many were left wondering where and when they would get the vaccine. With 90% of the American population living within 5 miles of a community pharmacy, vaccine distribution to these locations is vital for a successful vaccine campaign. The Biden Administration launched the Federal Retail Pharmacy Program (FRPP) in February 2021, a public-private partnership with 21 national pharmacy partners representing over 40,000 pharmacy locations to help expand the vaccine rollout. Community pharmacists are uniquely positioned to fulfill this mission by being a point of contact for the COVID-19 vaccination efforts. The FRPP has experienced some limitations, including the variable vaccine allocation, limited support from the healthcare system, and the lack of overwhelming public confidence in the vaccines. Improving the FRPP would require strong partnership with other healthcare professionals and the adoption of flexible vaccine dissemination. These can stem future pandemics.

show abstract

Section: Description Of the Policymentioning

confidence: 99%

Section: Description Of the Policymentioning

confidence: 99%

Section: Benefits Of the Policymentioning

confidence: 99%

Section: Benefits Of the Policymentioning

confidence: 99%

Section: Limitations Of the Policymentioning

confidence: 99%

See 3 more Smart Citations

The Federal Retail Pharmacy Program (FRPP) Impact on COVID-19 Vaccine Distribution During Pandemic: Effectiveness, Limitations, and Implications

Wilson

Aremu²

2022

Innov Pharm

View full text Add to dashboard Cite

show abstract

Need for open data on COVID-19 vaccine uptake among pregnant people in the Caribbean: a call to action

Pinkney,

Carroll,

Rich

et al. 2023

Revista Panamericana De Salud Pública

View full text Add to dashboard Cite

Pregnant people with coronavirus disease 2019 (COVID-19) have a higher risk of adverse maternal and fetal outcomes compared with pregnant people without COVID-19. In 2021, large increases in maternal mortality were reported in Jamaica, almost half of which were attributable to COVID-19. COVID-19 vaccination has been shown to reduce these risks, but low- and middle-income countries lack free, publicly available data, known as open data, on COVID-19 vaccine uptake for their pregnant populations. The objectives of this paper were to: review how high-income countries use open data to detect trends in COVID-19 vaccine uptake among pregnant people and develop vaccination distribution strategies; outline barriers to making open data available for maternal COVID-19 vaccination in the Caribbean; and propose a multipronged strategy that would increase the availability of open data on maternal COVID-19 vaccination in the Caribbean. A multipronged strategy to fill the data void would involve: (i) utilizing existing Caribbean maternal immunization data collection entities; (ii) adapting digital software tools to establish maternal electronic immunization registries; and (iii) collaborating with local partners skilled in data analytics. Making open data available for COVID-19 vaccine uptake among pregnant people in the Caribbean could offer substantial benefits, including the development of measurable maternal COVID-19 vaccination goals and the facilitation of vaccine decision-making discussions between providers and pregnant people.

show abstract

Harnessing the Power of Collaboration to Expand the Coverage and Equity of COVID-19 Vaccinations in India: A Community Collaboration Model

Soni¹,

Seth²,

Arora³

et al. 2023

Vaccines

View full text Add to dashboard Cite

Early in 2021, India embarked on the uphill journey of the COVID-19 vaccination of the largest population group in the world in a prioritized manner and in the shortest possible time. Considering the endless variety of geography and diverse socio-economic demographic, religious, and community contexts, there was a high likelihood of certain population subgroups with known vulnerabilities facing inequities, which were anticipated to be further accentuated by a digital divide. This necessitated devising solutions for such communities in a localized manner to aid the local government in breaking the service access and uptake barriers with an inclusive approach. To bridge this vital gap, the Momentum Routine Immunization Transformation and Equity project implemented a three-tiered collaboration, viz., government, non-governmental organizations (NGOs), and a wide range of vulnerable and at-risk communities, utilizing knowledge exchange and use of data. The project implemented localization strategies through the NGOs for community engagement in conjunction with government vaccination teams to universalize COVID-19 vaccination uptake up to the last mile. The collaboration resulted in reaching close to 50 million beneficiaries through messaging and facilitated the administration of more than 14 million vaccine doses, including 6.1 million doses for vulnerable and marginalized communities in 18 States and Union territories in India, along with suggesting implications for public health practice and research.

show abstract

Using Influenza Vaccination Location Data from the 2018 Behavioral Risk Factor Surveillance System (BRFSS) to Expand COVID-19 Vaccination Coverage

Cited by 3 publications

References 23 publications

The Federal Retail Pharmacy Program (FRPP) Impact on COVID-19 Vaccine Distribution During Pandemic: Effectiveness, Limitations, and Implications

The Federal Retail Pharmacy Program (FRPP) Impact on COVID-19 Vaccine Distribution During Pandemic: Effectiveness, Limitations, and Implications

Need for open data on COVID-19 vaccine uptake among pregnant people in the Caribbean: a call to action

Harnessing the Power of Collaboration to Expand the Coverage and Equity of COVID-19 Vaccinations in India: A Community Collaboration Model

Contact Info

Product

Resources

About